$3495 | Single User
$6990 | Site License
$10485 | Global License

Acute Coronary Syndrome: Competitive Landscape to 2026 [Report Updated: 30-06-2018]

Published by Global Data: 30 Jun 2018 | 216518 | In Stock

Introduction

Acute Coronary Syndrome: Competitive Landscape to 2026

Summary

Acute coronary syndrome (ACS) refers to a spectrum of myocardial ischemic states caused by the disruption of atherosclerotic plaques in the coronary arteries. The syndrome is precipitated by coronary artery occlusion (stenosis), which results in ischemia and myocardial necrosis. The development of ACS is heavily influenced by diet and lifestyle, and can manifest as myocardial infarction (MI) or unstable angina (UA).

This report provides an assessment of the pipeline, clinical, and commercial landscape of ACS. Overall, GlobalData expects new drug approvals to drive ACS market growth over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -

- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type

- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics

- Commercial Assessment: leading marketed products, current and future players

- Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Acute Coronary Syndrome market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Acute Coronary Syndrome market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents
for Acute Coronary Syndrome: Competitive Landscape to 2026 [Report Updated: 30-06-2018]

  • Table of Contents

    1. Preface 2

    1.1 Table of Contents 2

    1.2 Abbreviations 3

    1.3 Related Reports 4

    1.4 Upcoming Related Reports 5

    2. Executive Summary 6

    2.2 Key Findings 7

    2.2 Key Events 8

    3. Introduction 9

    3.1 Report Scope 10

    3.2 Disease Overview and Epidemiology 12

    4. Pipeline Assessment 15

    4.1 Pipeline Overview 16

    4.2 Pipeline Breakdown by Region/Country 18

    4.3 Pipeline Breakdown by Molecule Type and Target 19

    4.4 Drug Review Designations 20

    4.5 Products in Clinical Development 21

    5. Clinical Trial Assessment 23

    5.1 Clinical Trials Overview 24

    5.2 Top Sponsors of Clinical Trials in Acute Coronary Syndrome 25

    5.3 Trial Breakdown by Region 27

    5.4 Therapy Area Perspective 28

    5.5 Enrollment Analytics 29

    6 Commercial Assessment 32

    6.1 Leading Marketed Products 33

    6.2 Current & Future Players 34

    7. Competitive Landscape Analysis (2016-2025) 35

    7.1 Events Classification Overview 36

    7.2 US 37

    7.3 5EU 38

    7.4 Japan/China 39

    8 Appendix 42

    8.1 Sources 43

    8.2 Methodology 45

    8.3 Key Events Included in the Analysis 46

    8.4 About the Authors 47

    8.5 About GlobalData 50

    8.6 Disclaimer 52

Additional Details

Publisher

Global Data

Publisher Information

Reference

216518 | GDHC010CL

Number of Pages

49

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016SummaryGlobal...
20 Apr 2016 by Global Data USD $2,500 More Info
Acute Pain Global Clinical Trials Review, H1, 2016
Acute Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acute ...
20 Apr 2016 by Global Data USD $2,500 More Info
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016SummaryGlobalData's clini...
29 Feb 2016 by Global Data USD $2,500 More Info
Acute Stress Disorder Global Clinical Trials Review, H2, 2015
Acute Stress Disorder Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial repo...
16 Dec 2015 by Global Data USD $2,500 More Info
Acute Injury Global Clinical Trials Review, H2, 2015
Acute Injury Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Acut...
09 Dec 2015 by Global Data USD $2,500 More Info
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial ...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute and Sub-Acute Bursitis Global Clinical Trials Review, H2, 2015
Acute and Sub-Acute Bursitis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tri...
25 Nov 2015 by Global Data USD $2,500 More Info
Altitude Sickness (Acute mountain sickness) Global Clinical Trials Review, H2, 2015
Altitude Sickness (Acute mountain sickness) Global Clinical Trials Review, H2, 2015SummaryGlobalData...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's ...
30 Oct 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Acute Coronary Syndrome: Competitive Landscape to 2026 [Report Updated: 30-06-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data